Updated: December 5, 2020 2:25:51 pm
Bharat Biotech is developing the vaccine in collaboration with the National Institute of Virology and the Indian Council for Medical Research.
Hyderabad-based Bharat Biotech said on Saturday that the efficacy of its vaccine, Covaxin, for the novel, could be determined only 14 days after a second dose. He said his clinical trials were based on a two-dose schedule, administered 28 days apart.
The company’s clarification came hours after Haryana Health Minister Anil Vij, who had been given an injection of Covaxin about two weeks ago as part of his clinical trials, said that it tested positive for .
“Covaxin clinical trials are based on a two-dose schedule, 28 days apart. The efficacy of the vaccine will be determined 14 days after the second dose. Covaxin has been designed to be effective when subjects receive both doses, ”the biotech company said in a statement, the news agency reported. AND ME.
The company added that as part of the trial, 50 percent of the participants received the vaccine while the others were given a placebo. “Phase 3 trials are double-blind and randomized, where 50 percent of the subjects (trial participants) receive the vaccine and 50 percent of the subjects receive a placebo,” he said.
Vij had volunteered to participate in Bharat Biotech’s human phase trials, in which more than 25,000 people were given test doses. On November 20, Vij was the first in Haryana to receive the injection. In addition to him, more than 400 people from Haryana, including Rohtak PGIMS Vice Chancellor Dr. OP Kalra, participated in the trials.
A team from the Rohtak Graduate Institute of Medical Sciences had administered the vaccine to Vij at Ambala Cantonment civil hospital. Since then, his health and vital signs have been checked weekly.
Bharat Biotech is developing the vaccine in collaboration with the National Institute of Virology (NIV) and the Indian Council for Medical Research (ICMR). It is one of several indigenous vaccines that are being developed in the country.
© IE Online Media Services Pvt Ltd
.
